Clinical Trial: Predictive Value of Maternal Immune Inflammatory Markers in Late Pregnancy for Neonatal Acute Respiratory Distress Syndrome Based on Machine Learning Algorithms (China)

Posted On: 2026-09-30

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Predictive Value of Maternal Immune Inflammatory Markers in Late Pregnancy for Neonatal Acute Respiratory Distress Syndrome Based on Machine Learning Algorithms'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133593

Registration Time: 2026/09/29

Type: Observational study

Primary Sponsor: The first hospital of Shanxi Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345668

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Predictive Value of Maternal Immune Inflammatory Markers in Late Pregnancy for Neonatal Acute Respiratory Distress Syndrome Based on Machine Learning Algorithms (China)